Physician profile
Amanda Rogers
NPI 1225637564
$722.77
in general payments reported to CMS, 2019-2025
10 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.28 · 2022: $31.32 · 2023: $70.58 · 2024: $387 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $648.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immedica Pharma US, INC. | $160.37 | 2024 | |
| Neurelis, INC. | $144.08 | 2024 | Valtoco |
| Ucb, INC. | $143.54 | 2023-2025 | Fintepla, Nayzilam |
| Sumitomo Pharma America, INC. | $76.15 | 2023-2024 | Aptiom |
| Livanova USA, INC. | $66.11 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Cvrx, INC. | $38.88 | 2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $31.32 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.22 | 2021 | |
| Baxter Healthcare | $19.04 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Glaxosmithkline, LLC. | $17.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.